Health Check: AFT Pharmaceuticals girds for major iron deficiency therapy trial
Electrifying: Can ASX lithium stocks go ballistic again?
Experts say gold’s bull market is far from over
Top 10 at 11: ASX rides Nvidia’s rocket, Vintage Energy gets green light on PEP 171 exit
Lumos teams with AcuityMD to boost US rollout of FebriDx rapid diagnostic test
Argonaut Algorithm: Volatility doesn’t mean it’s time to jump ship, it’s about buying quality
Uvre locks in historic Invincible gold mine in NZ
Escape’s editors reveal where they go on holiday in summer, and it’s not where you think
Break it Down: Brightstar gets green light for Aurumin gold acquisition
Rise and Shine: Everything you need to know before the ASX opens
Contributors
Our Resident Experts
Mining
Experts say gold’s bull market is far from over
Argonaut Algorithm: Volatility doesn’t mean it’s time to jump ship, it’s about buying quality
Resources Top 5: Critical minerals power up as copper and silver join the charge
Bulk Buys: Surprise packets – where you could have doubled your money in bulks in 2025
Why Aussie graphite projects are beginning to turn investors’ heads
Featured in Mining
Tech
Chinese hackers ‘tricked’ Anthropic AI into launching cyber attacks
Why AI’s big short is not done yet
Defence dollars are surging, and ASX companies like Harvest Tech are plugged in
Rokt clinches US$7.9bn valuation in pre-IPO positioning frenzy
Younger Aussies beat power bills with payment hacks
Featured in Tech
Health & Biotech
Health Check: Crucial late-stage trial read-outs are ‘now in sight’
The art of the health deal: How strong data opens doors
Health Check: ALS waves off a Mexican drug testing downturn to post a 12pc profit rise
Biocurious: Inhalerx hones in on pot for pain and panic in its quest for historic drug approval
Bacterial or viral? Lumos moves to close a widening diagnostic gap as respiratory cases rise
Featured in Health & Biotech
Experts
Stock Tips: On the defensive, experts turn to packaging, infrastructure and gaming
Salary sacrifice falls out of favour as a super strategy
Criterion: The RBA might not lower rates again – but does it matter for shares?
Why a rental shortage is stopping sellers and fuelling home prices
Shutdown ends as markets brace for torrent of delayed US data
The next potential wealth tax coming for investors
Bonds well positioned to play a stronger role in investor portfolios
